The Region of Antithrombin Interacting with Full-Length Heparin Chains Outside the High-Affinity Pentasaccharide Sequence Extends to Lys136 but Not to Lys139-Reference-Cited by-同舟云学术

The Region of Antithrombin Interacting with Full-Length Heparin Chains Outside the High-Affinity Pentasaccharide Sequence Extends to Lys136 but Not to Lys139

Published:2000-06-24 Issue:29 Volume:39 Page:8512-8518
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Arocas Véronique¹,Turk Boris¹,Bock Susan C.¹,Olson Steven T.¹,Björk Ingemar¹

Affiliation:

1. Department of Veterinary Medical Chemistry, Swedish University of Agricultural Sciences, Uppsala Biomedical Center, Box 575, SE-751 23 Uppsala, Sweden, Departments of Medicine and Bioengineering, UUHSC−Pulmonary Division, University of Utah, Salt Lake City, Utah 84132, and Center for Molecular Biology of Oral Diseases, University of Illinois−Chicago, Chicago, Illinois 60612

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi9928243

Reference37 articles.

1. The Binding of Low-Affinity and High-Affinity Heparin to Antithrombin. Fluorescence Studies

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of glycosaminoglycan binding cyclic peptides using cPEPmatch;Computational and Structural Biotechnology Journal;2024-12

2. Distinct antithrombin activation modes for fondaparinux and natural heparins detected using millisecond hydrogen deuterium exchange and collision induced unfolding;International Journal of Biological Macromolecules;2024-07

3. Small-molecule modulators of serine protease inhibitor proteins (serpins);Drug Discovery Today;2021-02

4. Thrombin: An Approach to Developing a Higher-Order Reference Material and Reference Measurement Procedure for Substance Identity, Amount, and Biological Activities;Journal of Research of the National Institute of Standards and Technology;2020-07-29

5. Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies;Current Medicinal Chemistry;2020-06-15